March 25 (Reuters) - Haemonetics Corp:
* Completes tender offer for Global Med shares and commences subsequent
offering period
* Says 3,960 shares of preferred stock, approximately 31,428,730 shares of
common stock had been tendered
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Completes tender offer for Global Med shares and commences subsequent
offering period
* Says 3,960 shares of preferred stock, approximately 31,428,730 shares of
common stock had been tendered
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News
